These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
78 related items for PubMed ID: 9300698
1. Alternative peptide binding motifs of Qa-2 class Ib molecules define rules for binding of self and nonself peptides. Tabaczewski P, Chiang E, Henson M, Stroynowski I. J Immunol; 1997 Sep 15; 159(6):2771-81. PubMed ID: 9300698 [Abstract] [Full Text] [Related]
2. Qa-2 molecules are peptide receptors of higher stringency than ordinary class I molecules. Rötzschke O, Falk K, Stevanović S, Grahovac B, Soloski MJ, Jung G, Rammensee HG. Nature; 1993 Feb 18; 361(6413):642-4. PubMed ID: 8437623 [Abstract] [Full Text] [Related]
3. The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9. Braud V, Jones EY, McMichael A. Eur J Immunol; 1997 May 18; 27(5):1164-9. PubMed ID: 9174606 [Abstract] [Full Text] [Related]
4. Multiple class I motifs revealed by sequencing naturally processed peptides eluted from rat T cell MHC molecules. Burrows GG, Ariail K, Celnik B, Gambee JE, Offner H, Vandenbark AA. J Neurosci Res; 1997 Jul 01; 49(1):107-16. PubMed ID: 9211995 [Abstract] [Full Text] [Related]
5. A molecular basis for how a single TCR interfaces multiple ligands. Boesteanu A, Brehm M, Mylin LM, Christianson GJ, Tevethia SS, Roopenian DC, Joyce S. J Immunol; 1998 Nov 01; 161(9):4719-27. PubMed ID: 9794402 [Abstract] [Full Text] [Related]
8. Mapping of HLA class I binding motifs in forty-four fusion proteins involved in human cancers. Gambacorti-Passerini C, Bertazzoli C, Dermime S, Scardino A, Schendel D, Parmiani G. Clin Cancer Res; 1997 May 01; 3(5):675-83. PubMed ID: 9815736 [Abstract] [Full Text] [Related]
12. Peptide analysis, stability studies, and structural modeling explain contradictory peptide motifs and unique properties of the NOD mouse MHC class II molecule H2-A(g7). Münz C, Hofmann M, Yoshida K, Moustakas AK, Kikutani H, Stevanoviç S, Papadopoulos GK, Rammensee HG. Eur J Immunol; 2002 Aug 01; 32(8):2105-16. PubMed ID: 12209622 [Abstract] [Full Text] [Related]
13. A peptide binding motif for I-Eg7, the MHC class II molecule that protects E alpha-transgenic nonobese diabetic mice from autoimmune diabetes. Gregori S, Trembleau S, Penna G, Gallazzi F, Hammer J, Papadopoulos GK, Adorini L. J Immunol; 1999 Jun 01; 162(11):6630-40. PubMed ID: 10352280 [Abstract] [Full Text] [Related]
15. Rigidification of the alpha2 helix of an MHC class I molecule by a valine to proline mutation in position 165 does not prevent peptide-specific antigen presentation. Plaksin D, Polakova K, Mage MG, Margulies DH. J Immunol; 1997 Nov 01; 159(9):4408-14. PubMed ID: 9379039 [Abstract] [Full Text] [Related]
17. Differential role of conserved and polymorphic residues of the binding groove of MHC class I molecules in the selection of peptides. Abastado JP, Casrouge A, Kourilsky P. J Immunol; 1993 Oct 01; 151(7):3569-75. PubMed ID: 8376793 [Abstract] [Full Text] [Related]
18. Tumor defense by murine cytotoxic T cells specific for peptide bound to nonclassical MHC class I. Griffiths E, Ong H, Soloski MJ, Bachmann MF, Ohashi PS, Speiser DE. Cancer Res; 1998 Oct 15; 58(20):4682-7. PubMed ID: 9788622 [Abstract] [Full Text] [Related]
19. Structural basis of the differential stability and receptor specificity of H-2Db in complex with murine versus human beta2-microglobulin. Achour A, Michaëlsson J, Harris RA, Ljunggren HG, Kärre K, Schneider G, Sandalova T. J Mol Biol; 2006 Feb 17; 356(2):382-96. PubMed ID: 16375919 [Abstract] [Full Text] [Related]